290 likes | 298 Views
Explore the events leading to intestinal inflammation in IBD, the etiologic theories, and the genetics involved. Discover the efficacy, safety concerns, and adverse events associated with biologic therapies. Learn about the evidence for combination therapy and factors driving the loss of response to monoclonal anti-TNF antibodies.
E N D
Evidence for Combination Therapy in IBD in Immunosuppressive-naive Patients
What Drives Loss of Response to Monoclonal Anti-TNF Antibodies?